Assignee
CSL LTD
AU·87 granted patents·65 pending applications·888 citations·filing 1992–2025
Top patents by PatentIndex Score
152 records- 0194US11464828B2Reconstituted HDL formulationCSL LTD·Filed 2020·Granted Oct 11, 2022·3 cites·20 claims
- 0293US9125943B2Reconstituted HDL formulationCSL LTD·Filed 2013·Granted Sep 8, 2015·17 cites·25 claims
- 0393US7993637B2IL-11 muteinsCSL LTD·Filed 2008·Granted Aug 9, 2011·20 cites·11 claims
- 0492US9956269B2Method for improving the stability of purified factor VIII after reconstitutionCSL LTD·Filed 2016·Granted May 1, 2018·12 cites·18 claims
- 0592US9925236B2Reconstituted HDL formulationCSL LTD·Filed 2013·Granted Mar 27, 2018·7 cites·20 claims
- 0692US9340618B2IL-11R binding proteinsCSL LTD·Filed 2014·Granted May 17, 2016·22 cites·15 claims
- 0791US9439946B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2015·Granted Sep 13, 2016·10 cites·12 claims
- 0890US11058747B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2019·Granted Jul 13, 2021·3 cites·20 claims
- 0989US10881717B2Method for improving the stability of purified Factor VIII after reconstitutionCSL LTD·Filed 2019·Granted Jan 5, 2021·3 cites·24 claims
- 1088US9878017B2Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating theretoCSL LTD·Filed 2014·Granted Jan 30, 2018·4 cites·20 claims
- 1187US10603355B2Reconstructed HDL formulationCSL LTD·Filed 2018·Granted Mar 31, 2020·4 cites·20 claims
- 1287US10537616B2Method for improving the stability of purified factor VIII after reconstitutionCSL LTD·Filed 2018·Granted Jan 21, 2020·5 cites·18 claims
- 1387US10335457B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2016·Granted Jul 2, 2019·5 cites·20 claims
- 1487US9394353B2Method for improving the stability of purified factor VIII after reconstitutionCSL LTD·Filed 2012·Granted Jul 19, 2016·9 cites·7 claims
- 1587US7419671B2P. gingivalis antigenic compositionCSL LTD·Filed 2002·Granted Sep 2, 2008·24 cites·12 claims
- 1687US2025099537A1Reconstituted HDL FormulationCSL LTD·Filed 2024·Application pending·0 cites
- 1786US6093324APurification of immunoglobulinsCSL LTD·Filed 1997·Granted Jul 25, 2000·102 cites·20 claims
- 1886US2025051462A1Antibodies against g-csfr and uses thereofCSL LTD·Filed 2024·Application pending·0 cites
- 1985US11840573B2CD131 binding proteins and uses thereofCSL LTD·Filed 2020·Granted Dec 12, 2023·1 cites·20 claims
- 2085US10961304B2Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)CSL LTD·Filed 2019·Granted Mar 30, 2021·2 cites·20 claims
- 2185US10087235B2Contaminant removal methodCSL LTD·Filed 2014·Granted Oct 2, 2018·4 cites·13 claims
- 2285US9758585B2Compositions and methods for targeting type 1 interferon producing cellsCSL LTD·Filed 2015·Granted Sep 12, 2017·2 cites·16 claims
- 2385US6685947B1T helper cell epitopesCSL LTD·Filed 2000·Granted Feb 3, 2004·21 cites·16 claims
- 2485US2025122295A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2024·Application pending·0 cites
- 2585US2024226286A1Anti-tumor compositions and uses thereofCSL LTD·Filed 2023·Application pending·0 cites
- 2684US5902565ASpray dried vaccine preparation comprising aluminium adsorbed immunogensCSL LTD·Filed 1993·Granted May 11, 1999·70 cites·26 claims
- 2784US5593697ASingle dose vaccination systemCSL LTD·Filed 1992·Granted Jan 14, 1997·94 cites·15 claims
- 2883US11957731B2Reconstituted HDL formulationCSL LTD·Filed 2022·Granted Apr 16, 2024·0 cites·20 claims
- 2983US7776343B1Immunogenic complexes and methods relating theretoCSL LTD·Filed 2000·Granted Aug 17, 2010·21 cites·17 claims
- 3083US6306397B1Variants of human papilloma virus antigensCSL LTD·Filed 1999·Granted Oct 23, 2001·46 cites·33 claims
- 3182US10894834B2CD131 binding proteinsCSL LTD·Filed 2016·Granted Jan 19, 2021·2 cites·5 claims
- 3282US10730927B2Contaminant removal methodCSL LTD·Filed 2018·Granted Aug 4, 2020·2 cites·15 claims
- 3381US7204991B2Porphyromonas gingivalis recombinant proteins and truncationsCSL LTD·Filed 2002·Granted Apr 17, 2007·25 cites·10 claims
- 3481US6960463B2Separation of fibrinogen from plasma proteasesCSL LTD·Filed 2000·Granted Nov 1, 2005·13 cites·46 claims
- 3580US9796782B2Fibronectin III domain of IL-11RαCSL LTD·Filed 2015·Granted Oct 24, 2017·3 cites·14 claims
- 3679US10047161B2Humanized anti-interleukin 3 receptor alpha chain antibodiesCSL LTD·Filed 2015·Granted Aug 14, 2018·2 cites·4 claims
- 3779US9371388B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2013·Granted Jun 21, 2016·2 cites·4 claims
- 3879US7534441B2Immunogenic LHRH compositions and methods relating theretoCSL LTD·Filed 2005·Granted May 19, 2009·7 cites·7 claims
- 3979US6726912B1Papillomavirus polyprotein constructsCSL LTD·Filed 2001·Granted Apr 27, 2004·8 cites·23 claims
- 4079US2024216467A1Dosage regime for apolipoprotein formulationsCSL LTD·Filed 2023·Application pending·0 cites
- 4178US6004557AVariants of human papillomavirus antigensCSL LTD·Filed 1995·Granted Dec 21, 1999·36 cites·23 claims
- 4277US7169585B2Papillomavirus vaccineCSL LTD·Filed 2003·Granted Jan 30, 2007·6 cites·42 claims
- 4377US7114617B2ContainerCSL LTD·Filed 2003·Granted Oct 3, 2006·24 cites·41 claims
- 4477US2024174757A1Cd131 binding proteins and uses thereofCSL LTD·Filed 2023·Application pending·0 cites
- 4576US11723953B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2021·Granted Aug 15, 2023·0 cites·12 claims
- 4676US10421799B2Process for preparing Apolipoprotein A-I (Apo A-I)CSL LTD·Filed 2018·Granted Sep 24, 2019·1 cites·7 claims
- 4776US9890203B2Process for preparing apolipoprotein A-I (Apo A-I)CSL LTD·Filed 2014·Granted Feb 13, 2018·2 cites·18 claims
- 4876US9777062B2High affinity antibody antagonists of interleukin-13 receptor alpha 1CSL LTD·Filed 2016·Granted Oct 3, 2017·1 cites·10 claims
- 4976US6365160B1Papillomavirus polyprotein constructsCSL LTD·Filed 1996·Granted Apr 2, 2002·42 cites·20 claims
- 5074US11510968B2Method for improving the stability of purified Factor VIII after reconstitutionCSL LTD·Filed 2020·Granted Nov 29, 2022·0 cites·24 claims
Showing the top 50 of 152 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CSL LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →